Yuya Arai

Tokyo, Japan

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications

Sustained molecular response after discontinuation of ropeginterferon alfa-2b in a young patient with polycythemia vera

Sustained molecular response after discontinuation of ropeginterferon alfa-2b in a young patient with polycythemia vera

Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology
Published: March 29, 2026

Activity of Ponatinib and Vitamin K2 Against Myelodysplastic Syndrome and Acute Myeloid Leukemia Cells.

Activity of Ponatinib and Vitamin K2 Against Myelodysplastic Syndrome and Acute Myeloid Leukemia Cells.

Journal: Anticancer research
Published: December 24, 2025

Bi-directional association between RUNX1::RUNX1T1 and KIT mutations in acute myeloid leukemia: A multicenter genomic profiling study.

Bi-directional association between RUNX1::RUNX1T1 and KIT mutations in acute myeloid leukemia: A multicenter genomic profiling study.

Journal: Leukemia research
Published: December 21, 2025

Dual Proteasome and Histone Deacetylase Inhibition Overcomes Tyrosine Kinase Inhibitor Resistance in Breakpoint Cluster Region: Abelson 1-Driven Leukaemia Cell Lines.

Dual Proteasome and Histone Deacetylase Inhibition Overcomes Tyrosine Kinase Inhibitor Resistance in Breakpoint Cluster Region: Abelson 1-Driven Leukaemia Cell Lines.

Journal: Journal of cellular and molecular medicine
Published: November 06, 2025

Comparison of IPSS-R and IPSS-M in newly diagnosed myelodysplastic neoplasms: a single-center study

Comparison of IPSS-R and IPSS-M in newly diagnosed myelodysplastic neoplasms: a single-center study

Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology
Published: February 09, 2025

Therapeutic Potential of Venetoclax and Selinexor in Targeting Hypoxia-Induced Vulnerabilities in Multiple Myeloma.

Therapeutic Potential of Venetoclax and Selinexor in Targeting Hypoxia-Induced Vulnerabilities in Multiple Myeloma.

Journal: Cancer reports (Hoboken, N.J.)
Published: January 17, 2025

Correspondence to: "Combination therapies with ponatinib and asciminib in a preclinical model of chronic myeloid leukemia blast crisis with compound mutations", Curik N et al. Leukemia. 2024; 38: 1415-1418.

Correspondence to: "Combination therapies with ponatinib and asciminib in a preclinical model of chronic myeloid leukemia blast crisis with compound mutations", Curik N et al. Leukemia. 2024; 38: 1415-1418.

Journal: Leukemia
Published: December 21, 2024

Combination of WEE1 Inhibitor and Vitamin K2 Enhances Therapeutic Efficacy in Chronic Myeloid Leukemia.

Combination of WEE1 Inhibitor and Vitamin K2 Enhances Therapeutic Efficacy in Chronic Myeloid Leukemia.

Journal: Cancer innovation
Published: October 21, 2024

Vitamin K2 Protects Against SARS-CoV-2 Envelope Protein-Induced Cytotoxicity in Chronic Myeloid Leukemia Cells and Enhances Imatinib Activity.

Vitamin K2 Protects Against SARS-CoV-2 Envelope Protein-Induced Cytotoxicity in Chronic Myeloid Leukemia Cells and Enhances Imatinib Activity.

Journal: International journal of molecular sciences
Published: September 24, 2024

Targeting the insulin-like growth factor-1 receptor to overcome imatinib resistance in chronic myeloid leukemia.

Targeting the insulin-like growth factor-1 receptor to overcome imatinib resistance in chronic myeloid leukemia.

Journal: Discover oncology
Published: September 18, 2024

Glutaminase 1 plays critical roles in myelodysplastic syndrome and acute myeloid leukemia cells.

Glutaminase 1 plays critical roles in myelodysplastic syndrome and acute myeloid leukemia cells.

Journal: Cancer biomarkers : section A of Disease markers
Published: August 30, 2024

Ovarian hyperstimulation syndrome with controlled ovarian stimulation after induction therapy for Philadelphia chromosome-positive acute lymphoblastic leukemia

Ovarian hyperstimulation syndrome with controlled ovarian stimulation after induction therapy for Philadelphia chromosome-positive acute lymphoblastic leukemia

Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology
Published: March 06, 2024
Showing 1-12 of 15

Last Updated: 09/26/2026